Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR-DMD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Rochester
Sponsor:
Collaborators:
Newcastle University
University Medical Center Freiburg
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Robert Griggs, MD, University of Rochester
ClinicalTrials.gov Identifier:
NCT01603407
First received: April 3, 2012
Last updated: May 13, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2019
  Estimated Primary Completion Date: August 2019 (Final data collection date for primary outcome measure)